What caloric deficit on a cutting cycle?

Moderate deficit (-300 to -500 kcal/d under maintenance) for the majority of cases. The presence of AAS does not justify a more aggressive deficit: on the contrary, the anti-catabolic effect of androgens allows excellent results with a moderate deficit while preserving energy, sleep and training. Helms 2014 and Aragon 2017 (ISSN) recommend 0.5-1% of body weight/wk as optimal loss rate in natural competition; under AAS, aiming for 0.7-1.2% is realistic without degrading performance. Maintenance calculation: Mifflin-St Jeor + activity factor x 1.4-1.7.

How much protein on a cut under AAS?

2.2 to 2.8 g/kg lean mass/day. Helms 2014 (ISSN) suggests 2.3-3.1 g/kg lean mass for natural bodybuilders in prolonged deficit; under AAS, the anti-catabolic effect of androgens allows targeting the lower range (2.2-2.5 g/kg) without compromising muscle preservation. Spread across 4-5 meals/day of 30-50 g (Schoenfeld 2018: no benefit beyond ~0.4 g/kg/meal in terms of protein synthesis). Sources: lean meat, eggs, fish, whey, late casein snack.

Is cardio needed under a cutting cycle?

Yes, but moderate. 3-4 sessions/wk of moderate cardio (LISS, 30-45 min, 60-70% MHR) or 2-3 short HIIT sessions (15-20 min). Cardio amplifies the caloric deficit and improves lipid profile (HDL up, counterbalancing AAS effect that degrades it). Avoid excessive cardio (>5h/wk) which may compromise muscle recovery and amplify cumulative fatigue. Fasted cardio in the morning: modest effect on lipolysis vs cardio at any time of day (Aragon 2013) — choose timing based on preference and adherence.

Anavar or Winstrol for cutting?

Anavar for prolonged cuts and first cycles (better tolerance, joints preserved). Winstrol for pre-competition 'finishing' (last 4-6 wk, maximum visual hardness). Both are 17α-alkylated and hepatotoxic. Comparative safety: Anavar slightly less hepatotoxic than Winstrol (Niedfeldt 2018), unfavorable lipid profile for both. Joints: Winstrol causes synovial dryness and significant joint pain — Anavar neutral. Women: Anavar almost exclusively (5-10 mg/d) because Winstrol causes virilization in ~30% of women at 10 mg/d.

How much fat can be lost per week on cycle?

0.7 to 1.2% of body weight/week is realistic and durable under AAS (Helms 2014 — extrapolation for 'enhanced' users). For a 90 kg user, that represents 0.6 to 1.1 kg/wk fat loss with excellent muscle preservation. Beyond 1.5% body weight/wk, muscle loss risk increases significantly even under AAS, and training performance degrades. Over 8 weeks at 1%/wk: -7-8 kg fat for a 90 kg subject, ~9% body fat less (if baseline 18%, end of cycle ~9-10%).

What PCT after a cut?

PCT identical to mass cycles, but timing to adjust according to esters used. Test E + Anavar cycle (long esters): PCT at W+3 post-last injection. Test P + Tren A cycle (short esters): PCT at W+3 days. Standard protocol: Nolvadex 40/40/20/20 mg/d for 4 wk. On a cut, the post-cycle window is particularly sensitive to cortisol rebound and fat regain (rebound effect). Maintain nutrition at maintenance level (not surplus) for 6-8 weeks post-PCT, and reduce cardio gradually. Reference: Rahnema 2014 (ASIH).

Clenbuterol: real safety and dosages?

Clenbuterol is not a harmless product despite its 'mainstream burner' reputation. Spiller 2013 documents cases of acute intoxication (tachycardia, hypokalemia, atrial fibrillation) from 200-300 µg single doses. Cautious dosing: progressive 14-day ramp from 20 → 100 µg/d, ceiling at 120 µg/d, 2 wk on / 2 wk off cycling to limit β2 receptor downregulation (Kamalakkannan 2008). Supplement with taurine (3-5 g/d) and magnesium (400 mg/d) to limit cramps. Contraindicated in subjects with cardiac history, severe anxiety or uncontrolled hypertension.

Recomposition vs pure cut: which strategy?

Recomposition (simultaneous muscle gain + fat loss) is feasible under AAS, but requires precise conditions: intermediate user (not beginner nor elite), moderate baseline body fat (12-18%), AAS with recomposition effect (trenbolone, primobolan). Strategy: very light caloric deficit (-100 to -200 kcal/d) or maintenance, elevated protein (2.5 g/kg lean mass), high training volume. Expected gains: +1-2 kg lean mass and -2-4 kg fat over 10 weeks. Pure cut (deficit -400 kcal/d) remains more predictable and more effective for very low body compositions (<10% fat).

Best cutting cycles in 2026 (10 protocols ranked by efficacy)

Methodology

Rankings based on 4 weighted criteria for cutting. (1) Fat loss efficacy: kg of fat mass lost over 8-10 weeks at controlled caloric deficit (-400 kcal/d average) with maintained training. (2) Lean mass preservation: ratio of lean mass preserved / fat mass lost, ideally measured via DEXA. A good protocol preserves >95% of lean mass despite prolonged deficit (Helms 2014 — ISSN bodybuilders nutrition). (3) Visual quality: muscle hardness, vascularity, lower subcutaneous retention, muscle separation — central criteria for competitive athletes. (4) Safety profile: hepatotoxicity (orals), lipid profile (HDL/LDL), blood pressure (Hartgens 2004), psychology (anxiety, irritability, sleep disturbances — particularly marked with trenbolone and clenbuterol). Protocols are ranked from most accessible to most advanced. Primary sources: Hartgens 2004, Strawford 1999, Wolf 2006, Helms 2014, Aragon 2017, Hartgens 2004 lipoproteins.

1. Test E 300 mg/wk + Anavar 50 mg/d (8 wk) — the entry cut
The most accessible and best-documented protocol for a first cut under AAS. Testosterone at moderate dose (300 mg/wk) maintains the androgenic environment necessary for muscle preservation in caloric deficit, while Anavar (oxandrolone) adds a marked anti-catabolic effect without aromatization or water retention. Strawford 1999 (RCT, oxandrolone 20 mg/d in HIV) documents +3.4 kg lean mass in 12 wk, which translates to excellent preservation under caloric deficit.
Dose / Duration
Test enanthate 300 mg/wk for 8-10 wk + Anavar 40-60 mg/d for 6-8 wk. AI only if needed (anastrozole 0.25 mg E3D). Hepatoprotectors (TUDCA 500 mg, NAC 1200 mg).
Target audience
First cuts under AAS, users having done 1-2 mass cycles, seeking a 'clean' result without excess side effects. Excellent for mass-to-definition transition.
Pros
- + Maximum tolerance, well-documented side-effect profile
- + Excellent lean mass preservation (Strawford 1999)
- + No water retention — rapid visual results
- + Simple PCT (Nolvadex 40/40/20/20)
- + Compatible with first AAS protocol
Cons
- − Anavar 17α-alkylated: ALT/AST to monitor (Niedfeldt 2018)
- − Lipid profile degraded (HDL -30% under Anavar)
- − High Anavar cost (~$150-200 cycle), frequent counterfeits
- − Modest strength gains — suited to cutting, not strength
- − Moderate but real HPG suppression
2. Test P + Tren A + Winstrol (8 wk) — the pre-competition cut
The 'king stack' of bodybuilding pre-contest. Testosterone propionate (short ester, water control), trenbolone acetate (recomposition effect + visual hardness), oral winstrol (muscle separation, vascularity). Elite pharmacological profile: short esters allow fine adjustments and rapid stop approaching peak. Cumulative heavy side effects: insomnia, night sweats, aggression, blood pressure, hepatotoxicity.
Dose / Duration
Test propionate 100 mg E2D + Trenbolone acetate 75 mg E2D + Winstrol 50 mg/d for 6-8 wk. Daily or E2D injections. AI mandatory (anastrozole). Cabergoline 0.25 mg 2x/wk. Hepatoprotectors.
Target audience
Bodybuilders pre-contest (8 wk before stage), advanced users having done 4+ cycles, quarterly biological monitoring, accessible medical support. Not for amateur or first cut.
Pros
- + Maximum visual quality: hardness, vascularity, separation
- + Recomposition possible (simultaneous mass gain + fat loss)
- + Short kinetics allow fine peak control
- + "Confidence" psychological effect appreciated by competitors
- + Empirically validated by 40 years of competitive bodybuilding
Cons
- − Massive night sweats, insomnia, anxiety (Pope 2000 — mood mania)
- − Elevated blood pressure — cardiovascular risk (Baggish 2017)
- − Winstrol hepatotoxicity (Niedfeldt 2018)
- − Frequent injections (daily or E2D)
- − Difficult PCT, long HPG recovery
3. Test E 250 mg/wk + Masteron 400 mg/wk (10 wk) — the aesthetic cut
Masteron (drostanolone) propionate or enanthate is the quintessential 'aesthetic' AAS: DHT-derived non-aromatizing, antiestrogenic (displaces testosterone from SHBG, increasing free testosterone — Saartok 1984), no water retention. At moderate dose 400 mg/wk with testosterone 250 mg/wk, durable cut with excellent visual quality. Appreciated from the 3rd cycle.
Dose / Duration
Test enanthate 250 mg/wk + Masteron enanthate 400 mg/wk for 10-12 wk (or Masteron propionate 100 mg E2D for 8 wk for rapid transition). AI rarely needed (E2 naturally low).
Target audience
Aesthetic bodybuilders (models, photoshoots), advanced users (3rd cycle+), solid hair genetics, substantial budget. Not for first cycle or for users with early-stage alopecia.
Pros
- + No water retention — visibly thin skin
- + Antiestrogenic effect: E2 lowered without need for AI
- + Premium aesthetic profile: hardness, vascularity
- + Excellent general tolerance (Chowdhury 1976)
- + Low HPG suppression compared to tren or nandrolone
Cons
- − High cost (~$400-600 complete cycle)
- − Black market: frequent under-dosed masteron
- − Accelerated hair loss (DHT-derived) — sensitive genetics excluded
- − Potential back acne
- − E2 possibly too low if combined with AI: libido collapse
4. Test E 200 mg/wk + Tren E 200 mg/wk (10 wk) — the recomposition cut
'Slow' variant of the tren stack: trenbolone enanthate 200 mg/wk instead of acetate, allowing 2 injections/wk instead of daily. Marked body recomposition: fat loss + lean mass maintenance or even gain, even at moderate deficit. Tren profile remains heavy (sweats, insomnia, anxiety, unfavorable cardiovascular ratio).
Dose / Duration
Test enanthate 200 mg/wk + Trenbolone enanthate 200 mg/wk for 10-12 wk. Titrated AI (anastrozole 0.25 mg E3D). Cabergoline 0.25 mg 2x/wk. No oral to limit overall load.
Target audience
Advanced users (3rd cycle+), seeking recomposition vs simple cut, stable psychology, cardiovascular monitoring in place. Not for first cut.
Pros
- + Recomposition possible: simultaneous muscle gain + fat loss
- + Logistical comfort (2 injections/wk)
- + Marked visual hardness effect
- + No water retention
- + IGF-1 increase and nutrient partitioning (Yarrow 2011)
Cons
- − Tren profile: sweats, insomnia, anxiety, tren-cough on injection
- − Elevated blood pressure
- − Deep and long HPG suppression
- − Not for anxious users or those with psychiatric history (Piacentino 2015)
- − Moderate-high cost
5. Test E + Primobolan 300/400 mg/wk (12 wk) — the premium cut
The 'Rolex stack': moderate testosterone + primobolan, considered the 'cleanest' cutting cycle in the AAS landscape. Non-aromatizing methenolone enanthate, mild antiestrogenic, marked anti-catabolic effect. Ideal for long cuts without excessive lipid degradation. Astronomical cost and counterfeit-saturated black market (Magnolini 2022) remain the main obstacles.
Dose / Duration
Test enanthate 300 mg/wk + Methenolone enanthate (Primobolan) 400-500 mg/wk for 12-14 wk. AI rarely needed. hCG 250 IU 2x/wk optional.
Target audience
Very experienced users (4th cycle+), premium budget, reliable primobolan source, seeking a prolonged cut with maximum health preservation. Excellent for 35+ years old.
Pros
- + Among the best safety profiles of cutting stacks
- + No aromatization, no retention
- + Low HPG suppression compared to tren or nandrolone
- + Excellent digestive and hepatic tolerance
- + Exceptional lean mass preservation
Cons
- − Exorbitant cost (~$700-1000 complete cycle)
- − Frequent black-market counterfeits (~60-70%)
- − Less "spectacular" visual gains than with tren
- − Large injection volumes (often 100 mg/ml concentration)
- − Rare reliable sources
6. Test E + Anavar + Winstrol sequence (10 wk) — the "refining" cut
Cutting protocol in two sequenced blocks: Anavar W1-W6 (anti-catabolic kickstart) then Winstrol W7-W10 (final pre-peak hardness). Avoids stacking the two 17α-alkylated orals simultaneously (which would double the hepatic load without net anabolic benefit). Excellent for mass-to-definition transition spread over 10 weeks.
Dose / Duration
Test enanthate 250 mg/wk for 10 wk. Anavar 50 mg/d during W1-W6, 2-wk window (W5-W6), then Winstrol 50 mg/d during W7-W10. AI rarely needed. Continuous hepatoprotectors.
Target audience
Intermediate users (2nd-3rd cycle), mass-to-definition transition, solid baseline (HDL >50, normal transaminases). Not for first cut.
Pros
- + Avoids hepatic stacking of two orals
- + Phase 1 (Anavar): lean mass preservation
- + Phase 2 (Winstrol): final visual hardness
- + Progressive and controlled visual effects
- + Intermediate cost
Cons
- − Severely degraded lipid profile (two 17α-alkylated orals in sequence)
- − Cumulative hepatic load over 10 weeks
- − Joint dryness during Winstrol phase — possible pain
- − PCT startable only after complete stop
- − Not suited to borderline baseline lipids
7. Test E + Halotestin (4 wk at end) — the pure competition cut
Halotestin (fluoxymesterone) is the most androgenic and most hepatotoxic oral in the AAS landscape, reserved for the last 4 weeks pre-competition. Increases raw strength and aggression without aromatization, without retention. 'Pump-up' psychological effect before stage. Very short use (max 4 wk) exclusively for advanced competitors.
Dose / Duration
Test enanthate 200 mg/wk for 10 wk + Halotestin 10-20 mg/d for last 4 wk pre-contest. AI as needed. High-dose hepatoprotectors. Weekly liver bloodwork.
Target audience
Advanced competitive bodybuilders and powerlifters (5th cycle+), pre-competition only, medical support and quarterly biological monitoring. Strictly not recommended outside competition.
Pros
- + Maximum strength and power pre-competition
- + No water retention
- + Psychological "stage confidence" effect
- + Marked visual hardness in synergy with caloric deficit
- + Fast elimination post-stop
Cons
- − Among the highest hepatotoxicity of orals (Hudson 1959, Niedfeldt 2018)
- − Marked aggression ("halo-rage") — Pope 2000
- − Catastrophic lipid profile
- − High cost
- − Very limited black-market availability
8. Test E + Clenbuterol cycled (10 wk + clen 2 on/2 off) — the fat-burner cut
Combines the androgenic base (testosterone) with a clenbuterol cycle (β2 agonist) to amplify lipolysis. Clenbuterol is cycled 2 wk on / 2 wk off to limit β2 receptor downregulation (Kamalakkannan 2008). Marked thermogenic effect: +5 to +10% resting energy expenditure. Significant cardiovascular side effects (tachycardia, tremors).
Dose / Duration
Test enanthate 300 mg/wk for 10 wk + Clenbuterol cycling 2 wk on / 2 wk off, progressive ramp 20→120 µg/d (Spiller 2013: do not exceed 140 µg/d in practice). Ketotifen 1-2 mg/d optional to resensitize receptors.
Target audience
Intermediate users (2nd cycle+) on moderate cut, no cardiovascular history, daily HR and blood pressure monitoring. Not for anxious users or those sensitive to stimulants.
Pros
- + Lipolysis amplified by thermogenic effect
- + Modest recomposition effect without additional aromatization
- + Clen cycle allows intermittent use without additional HPG suppression
- + Moderate clen availability on the market
- + Moderate cost
Cons
- − Tachycardia, tremors, palpitations (Daubert 2007)
- − Muscle cramps (taurine and magnesium deficits)
- − Anxiety and sleep disturbances
- − Cardiac risk in susceptible users (Burniston 2002: cardiomyocyte apoptosis in rat)
- − Acute toxicity documented at high doses (Spiller 2013)
9. Test E + T3 cytomel (8 wk) — the metabolic cut
Combines the androgenic base (testosterone, which preserves lean mass against the potential catabolic effect of T3) with T3 (triiodothyronine) at physiological doses (25-50 µg/d) to amplify basal metabolism. Without testosterone, T3 alone can be catabolic. At high doses (>75 µg/d), risk of thyroid axis suppression — limit and cycle progressively (Wiersinga 2012).
Dose / Duration
Test enanthate 400 mg/wk for 8-10 wk + T3 cytomel 25-50 µg/d for 6-8 wk (progressive ramp 12.5 → 25 → 50 µg over 2 wk, symmetric taper). Do not exceed 75 µg/d.
Target audience
Intermediate users (2nd-3rd cycle+), sluggish metabolism, cut stalled by metabolic stagnation. Not for users with baseline thyroid dysfunction.
Pros
- + Basal metabolism increased by 15-25%
- + Testosterone protects from T3 muscle catabolism
- + Very accessible cost (cheap T3)
- + Good tolerance at physiological doses
- + Visible effect on body composition in 3-4 wk
Cons
- − Risk of thyroid axis suppression if overdose or long cycle
- − Muscle catabolism if AAS dose insufficient
- − Palpitations, tremors at high doses
- − Excessive sweating, paradoxical fatigue
- − Thyroid recovery 2-4 wk post-stop required
10. Test E + Anavar + Cardarine (GW501516) (10 wk) — the endurance cut
Combines androgenic base (moderate Test E) + anti-catabolic (Anavar) + PPARδ agonist (Cardarine). Cardarine is neither a SARM nor an AAS but a PPARδ activator: amplifies lipid oxidation and endurance (Narkar 2008). Uncertain long-term safety profile — preclinical rodent studies have reported carcinogenic risk at high doses (Mitchell 2019; open debate on human extrapolation).
Dose / Duration
Test enanthate 250 mg/wk for 10 wk + Anavar 40 mg/d for 8 wk + Cardarine 10-20 mg/d for 8-10 wk. AI as needed. Hepatoprotectors.
Target audience
Advanced users accepting the cardarine risk profile, endurance + composition athletes, seeking metabolic optimization. Not for risk-averse users or those with family history of cancer.
Pros
- + Recomposition + improved endurance effect
- + Cardarine does not suppress HPG axis
- + Lipolysis (cardarine) + anti-catabolism (anavar) + androgen (test) synergy
- + Increased cardio performance (useful for HIIT training)
- + No additional aromatization
Cons
- − Controversial cardarine: carcinogenic risk signaled in rodents (Mitchell 2019)
- − Black market: highly variable cardarine product quality
- − Unclear legal status (WADA-banned, available as "research chemical")
- − No long-term human clinical studies
- − Moderate-high cost depending on cardarine source

Final comparison

Protocol	Fat loss 8 wk	Mass preservation	Visual quality	Safety
Test + Anavar	-4 to -6 kg	Excellent	Good	Very good
Test P + Tren A + Winstrol	-6 to -8 kg	Excellent	Maximum	Low
Test + Masteron	-4 to -6 kg	Excellent	Very good	Good
Test + Tren E	-5 to -7 kg	Excellent (gain possible)	Excellent	Medium-low
Test + Primobolan	-4 to -5 kg	Excellent	Very good	Excellent
Test + Anavar + Winstrol	-5 to -7 kg	Good	Excellent	Medium
Test + Halotestin	-3 to -5 kg	Good	Excellent	Low
Test + Clenbuterol	-5 to -7 kg	Good	Good	Medium
Test + T3	-5 to -7 kg	Medium	Good	Medium
Test + Anavar + Cardarine	-5 to -7 kg	Very good	Good	Uncertain (cardarine)

FAQ

What caloric deficit on a cutting cycle?: Moderate deficit (-300 to -500 kcal/d under maintenance) for the majority of cases. The presence of AAS does not justify a more aggressive deficit: on the contrary, the anti-catabolic effect of androgens allows excellent results with a moderate deficit while preserving energy, sleep and training. Helms 2014 and Aragon 2017 (ISSN) recommend 0.5-1% of body weight/wk as optimal loss rate in natural competition; under AAS, aiming for 0.7-1.2% is realistic without degrading performance. Maintenance calculation: Mifflin-St Jeor + activity factor x 1.4-1.7.
How much protein on a cut under AAS?: 2.2 to 2.8 g/kg lean mass/day. Helms 2014 (ISSN) suggests 2.3-3.1 g/kg lean mass for natural bodybuilders in prolonged deficit; under AAS, the anti-catabolic effect of androgens allows targeting the lower range (2.2-2.5 g/kg) without compromising muscle preservation. Spread across 4-5 meals/day of 30-50 g (Schoenfeld 2018: no benefit beyond ~0.4 g/kg/meal in terms of protein synthesis). Sources: lean meat, eggs, fish, whey, late casein snack.
Is cardio needed under a cutting cycle?: Yes, but moderate. 3-4 sessions/wk of moderate cardio (LISS, 30-45 min, 60-70% MHR) or 2-3 short HIIT sessions (15-20 min). Cardio amplifies the caloric deficit and improves lipid profile (HDL up, counterbalancing AAS effect that degrades it). Avoid excessive cardio (>5h/wk) which may compromise muscle recovery and amplify cumulative fatigue. Fasted cardio in the morning: modest effect on lipolysis vs cardio at any time of day (Aragon 2013) — choose timing based on preference and adherence.
Anavar or Winstrol for cutting?: Anavar for prolonged cuts and first cycles (better tolerance, joints preserved). Winstrol for pre-competition 'finishing' (last 4-6 wk, maximum visual hardness). Both are 17α-alkylated and hepatotoxic. Comparative safety: Anavar slightly less hepatotoxic than Winstrol (Niedfeldt 2018), unfavorable lipid profile for both. Joints: Winstrol causes synovial dryness and significant joint pain — Anavar neutral. Women: Anavar almost exclusively (5-10 mg/d) because Winstrol causes virilization in ~30% of women at 10 mg/d.
How much fat can be lost per week on cycle?: 0.7 to 1.2% of body weight/week is realistic and durable under AAS (Helms 2014 — extrapolation for 'enhanced' users). For a 90 kg user, that represents 0.6 to 1.1 kg/wk fat loss with excellent muscle preservation. Beyond 1.5% body weight/wk, muscle loss risk increases significantly even under AAS, and training performance degrades. Over 8 weeks at 1%/wk: -7-8 kg fat for a 90 kg subject, ~9% body fat less (if baseline 18%, end of cycle ~9-10%).
What PCT after a cut?: PCT identical to mass cycles, but timing to adjust according to esters used. Test E + Anavar cycle (long esters): PCT at W+3 post-last injection. Test P + Tren A cycle (short esters): PCT at W+3 days. Standard protocol: Nolvadex 40/40/20/20 mg/d for 4 wk. On a cut, the post-cycle window is particularly sensitive to cortisol rebound and fat regain (rebound effect). Maintain nutrition at maintenance level (not surplus) for 6-8 weeks post-PCT, and reduce cardio gradually. Reference: Rahnema 2014 (ASIH).
Clenbuterol: real safety and dosages?: Clenbuterol is not a harmless product despite its 'mainstream burner' reputation. Spiller 2013 documents cases of acute intoxication (tachycardia, hypokalemia, atrial fibrillation) from 200-300 µg single doses. Cautious dosing: progressive 14-day ramp from 20 → 100 µg/d, ceiling at 120 µg/d, 2 wk on / 2 wk off cycling to limit β2 receptor downregulation (Kamalakkannan 2008). Supplement with taurine (3-5 g/d) and magnesium (400 mg/d) to limit cramps. Contraindicated in subjects with cardiac history, severe anxiety or uncontrolled hypertension.
Recomposition vs pure cut: which strategy?: Recomposition (simultaneous muscle gain + fat loss) is feasible under AAS, but requires precise conditions: intermediate user (not beginner nor elite), moderate baseline body fat (12-18%), AAS with recomposition effect (trenbolone, primobolan). Strategy: very light caloric deficit (-100 to -200 kcal/d) or maintenance, elevated protein (2.5 g/kg lean mass), high training volume. Expected gains: +1-2 kg lean mass and -2-4 kg fat over 10 weeks. Pure cut (deficit -400 kcal/d) remains more predictable and more effective for very low body compositions (<10% fat).

Best cutting cycles in 2026 (10 protocols ranked by efficacy)

Methodology

1. Test E 300 mg/wk + Anavar 50 mg/d (8 wk) — the entry cut

The most accessible and best-documented protocol for a first cut under AAS. Testosterone at moderate dose (300 mg/wk) maintains the androgenic environment necessary for muscle preservation in caloric deficit, while Anavar (oxandrolone) adds a marked anti-catabolic effect without aromatization or water retention. Strawford 1999 (RCT, oxandrolone 20 mg/d in HIV) documents +3.4 kg lean mass in 12 wk, which translates to excellent preservation under caloric deficit.

Dose / Duration

Test enanthate 300 mg/wk for 8-10 wk + Anavar 40-60 mg/d for 6-8 wk. AI only if needed (anastrozole 0.25 mg E3D). Hepatoprotectors (TUDCA 500 mg, NAC 1200 mg).

Target audience

First cuts under AAS, users having done 1-2 mass cycles, seeking a 'clean' result without excess side effects. Excellent for mass-to-definition transition.

Pros

+ Maximum tolerance, well-documented side-effect profile
+ Excellent lean mass preservation (Strawford 1999)
+ No water retention — rapid visual results
+ Simple PCT (Nolvadex 40/40/20/20)
+ Compatible with first AAS protocol

Cons

− Anavar 17α-alkylated: ALT/AST to monitor (Niedfeldt 2018)
− Lipid profile degraded (HDL -30% under Anavar)
− High Anavar cost (~$150-200 cycle), frequent counterfeits
− Modest strength gains — suited to cutting, not strength
− Moderate but real HPG suppression

2. Test P + Tren A + Winstrol (8 wk) — the pre-competition cut

The 'king stack' of bodybuilding pre-contest. Testosterone propionate (short ester, water control), trenbolone acetate (recomposition effect + visual hardness), oral winstrol (muscle separation, vascularity). Elite pharmacological profile: short esters allow fine adjustments and rapid stop approaching peak. Cumulative heavy side effects: insomnia, night sweats, aggression, blood pressure, hepatotoxicity.

Dose / Duration

Test propionate 100 mg E2D + Trenbolone acetate 75 mg E2D + Winstrol 50 mg/d for 6-8 wk. Daily or E2D injections. AI mandatory (anastrozole). Cabergoline 0.25 mg 2x/wk. Hepatoprotectors.

Target audience

Bodybuilders pre-contest (8 wk before stage), advanced users having done 4+ cycles, quarterly biological monitoring, accessible medical support. Not for amateur or first cut.

Pros

+ Maximum visual quality: hardness, vascularity, separation
+ Recomposition possible (simultaneous mass gain + fat loss)
+ Short kinetics allow fine peak control
+ "Confidence" psychological effect appreciated by competitors
+ Empirically validated by 40 years of competitive bodybuilding

Cons

− Massive night sweats, insomnia, anxiety (Pope 2000 — mood mania)
− Elevated blood pressure — cardiovascular risk (Baggish 2017)
− Winstrol hepatotoxicity (Niedfeldt 2018)
− Frequent injections (daily or E2D)
− Difficult PCT, long HPG recovery

3. Test E 250 mg/wk + Masteron 400 mg/wk (10 wk) — the aesthetic cut

Masteron (drostanolone) propionate or enanthate is the quintessential 'aesthetic' AAS: DHT-derived non-aromatizing, antiestrogenic (displaces testosterone from SHBG, increasing free testosterone — Saartok 1984), no water retention. At moderate dose 400 mg/wk with testosterone 250 mg/wk, durable cut with excellent visual quality. Appreciated from the 3rd cycle.

Dose / Duration

Test enanthate 250 mg/wk + Masteron enanthate 400 mg/wk for 10-12 wk (or Masteron propionate 100 mg E2D for 8 wk for rapid transition). AI rarely needed (E2 naturally low).

Target audience

Aesthetic bodybuilders (models, photoshoots), advanced users (3rd cycle+), solid hair genetics, substantial budget. Not for first cycle or for users with early-stage alopecia.

Pros

+ No water retention — visibly thin skin
+ Antiestrogenic effect: E2 lowered without need for AI
+ Premium aesthetic profile: hardness, vascularity
+ Excellent general tolerance (Chowdhury 1976)
+ Low HPG suppression compared to tren or nandrolone

Cons

− High cost (~$400-600 complete cycle)
− Black market: frequent under-dosed masteron
− Accelerated hair loss (DHT-derived) — sensitive genetics excluded
− Potential back acne
− E2 possibly too low if combined with AI: libido collapse

4. Test E 200 mg/wk + Tren E 200 mg/wk (10 wk) — the recomposition cut

'Slow' variant of the tren stack: trenbolone enanthate 200 mg/wk instead of acetate, allowing 2 injections/wk instead of daily. Marked body recomposition: fat loss + lean mass maintenance or even gain, even at moderate deficit. Tren profile remains heavy (sweats, insomnia, anxiety, unfavorable cardiovascular ratio).

Dose / Duration

Test enanthate 200 mg/wk + Trenbolone enanthate 200 mg/wk for 10-12 wk. Titrated AI (anastrozole 0.25 mg E3D). Cabergoline 0.25 mg 2x/wk. No oral to limit overall load.

Target audience

Advanced users (3rd cycle+), seeking recomposition vs simple cut, stable psychology, cardiovascular monitoring in place. Not for first cut.

Pros

+ Recomposition possible: simultaneous muscle gain + fat loss
+ Logistical comfort (2 injections/wk)
+ Marked visual hardness effect
+ No water retention
+ IGF-1 increase and nutrient partitioning (Yarrow 2011)

Cons

− Tren profile: sweats, insomnia, anxiety, tren-cough on injection
− Elevated blood pressure
− Deep and long HPG suppression
− Not for anxious users or those with psychiatric history (Piacentino 2015)
− Moderate-high cost

5. Test E + Primobolan 300/400 mg/wk (12 wk) — the premium cut

The 'Rolex stack': moderate testosterone + primobolan, considered the 'cleanest' cutting cycle in the AAS landscape. Non-aromatizing methenolone enanthate, mild antiestrogenic, marked anti-catabolic effect. Ideal for long cuts without excessive lipid degradation. Astronomical cost and counterfeit-saturated black market (Magnolini 2022) remain the main obstacles.

Dose / Duration

Test enanthate 300 mg/wk + Methenolone enanthate (Primobolan) 400-500 mg/wk for 12-14 wk. AI rarely needed. hCG 250 IU 2x/wk optional.

Target audience

Very experienced users (4th cycle+), premium budget, reliable primobolan source, seeking a prolonged cut with maximum health preservation. Excellent for 35+ years old.

Pros

+ Among the best safety profiles of cutting stacks
+ No aromatization, no retention
+ Low HPG suppression compared to tren or nandrolone
+ Excellent digestive and hepatic tolerance
+ Exceptional lean mass preservation

Cons

− Exorbitant cost (~$700-1000 complete cycle)
− Frequent black-market counterfeits (~60-70%)
− Less "spectacular" visual gains than with tren
− Large injection volumes (often 100 mg/ml concentration)
− Rare reliable sources

6. Test E + Anavar + Winstrol sequence (10 wk) — the "refining" cut

Cutting protocol in two sequenced blocks: Anavar W1-W6 (anti-catabolic kickstart) then Winstrol W7-W10 (final pre-peak hardness). Avoids stacking the two 17α-alkylated orals simultaneously (which would double the hepatic load without net anabolic benefit). Excellent for mass-to-definition transition spread over 10 weeks.

Dose / Duration

Test enanthate 250 mg/wk for 10 wk. Anavar 50 mg/d during W1-W6, 2-wk window (W5-W6), then Winstrol 50 mg/d during W7-W10. AI rarely needed. Continuous hepatoprotectors.

Target audience

Intermediate users (2nd-3rd cycle), mass-to-definition transition, solid baseline (HDL >50, normal transaminases). Not for first cut.

Pros

+ Avoids hepatic stacking of two orals
+ Phase 1 (Anavar): lean mass preservation
+ Phase 2 (Winstrol): final visual hardness
+ Progressive and controlled visual effects
+ Intermediate cost

Cons

− Severely degraded lipid profile (two 17α-alkylated orals in sequence)
− Cumulative hepatic load over 10 weeks
− Joint dryness during Winstrol phase — possible pain
− PCT startable only after complete stop
− Not suited to borderline baseline lipids

7. Test E + Halotestin (4 wk at end) — the pure competition cut

Halotestin (fluoxymesterone) is the most androgenic and most hepatotoxic oral in the AAS landscape, reserved for the last 4 weeks pre-competition. Increases raw strength and aggression without aromatization, without retention. 'Pump-up' psychological effect before stage. Very short use (max 4 wk) exclusively for advanced competitors.

Dose / Duration

Test enanthate 200 mg/wk for 10 wk + Halotestin 10-20 mg/d for last 4 wk pre-contest. AI as needed. High-dose hepatoprotectors. Weekly liver bloodwork.

Target audience

Advanced competitive bodybuilders and powerlifters (5th cycle+), pre-competition only, medical support and quarterly biological monitoring. Strictly not recommended outside competition.

Pros

+ Maximum strength and power pre-competition
+ No water retention
+ Psychological "stage confidence" effect
+ Marked visual hardness in synergy with caloric deficit
+ Fast elimination post-stop

Cons

− Among the highest hepatotoxicity of orals (Hudson 1959, Niedfeldt 2018)
− Marked aggression ("halo-rage") — Pope 2000
− Catastrophic lipid profile
− High cost
− Very limited black-market availability

8. Test E + Clenbuterol cycled (10 wk + clen 2 on/2 off) — the fat-burner cut

Combines the androgenic base (testosterone) with a clenbuterol cycle (β2 agonist) to amplify lipolysis. Clenbuterol is cycled 2 wk on / 2 wk off to limit β2 receptor downregulation (Kamalakkannan 2008). Marked thermogenic effect: +5 to +10% resting energy expenditure. Significant cardiovascular side effects (tachycardia, tremors).

Dose / Duration

Test enanthate 300 mg/wk for 10 wk + Clenbuterol cycling 2 wk on / 2 wk off, progressive ramp 20→120 µg/d (Spiller 2013: do not exceed 140 µg/d in practice). Ketotifen 1-2 mg/d optional to resensitize receptors.

Target audience

Intermediate users (2nd cycle+) on moderate cut, no cardiovascular history, daily HR and blood pressure monitoring. Not for anxious users or those sensitive to stimulants.

Pros

+ Lipolysis amplified by thermogenic effect
+ Modest recomposition effect without additional aromatization
+ Clen cycle allows intermittent use without additional HPG suppression
+ Moderate clen availability on the market
+ Moderate cost

Cons

− Tachycardia, tremors, palpitations (Daubert 2007)
− Muscle cramps (taurine and magnesium deficits)
− Anxiety and sleep disturbances
− Cardiac risk in susceptible users (Burniston 2002: cardiomyocyte apoptosis in rat)
− Acute toxicity documented at high doses (Spiller 2013)

9. Test E + T3 cytomel (8 wk) — the metabolic cut

Combines the androgenic base (testosterone, which preserves lean mass against the potential catabolic effect of T3) with T3 (triiodothyronine) at physiological doses (25-50 µg/d) to amplify basal metabolism. Without testosterone, T3 alone can be catabolic. At high doses (>75 µg/d), risk of thyroid axis suppression — limit and cycle progressively (Wiersinga 2012).

Dose / Duration

Test enanthate 400 mg/wk for 8-10 wk + T3 cytomel 25-50 µg/d for 6-8 wk (progressive ramp 12.5 → 25 → 50 µg over 2 wk, symmetric taper). Do not exceed 75 µg/d.

Target audience

Intermediate users (2nd-3rd cycle+), sluggish metabolism, cut stalled by metabolic stagnation. Not for users with baseline thyroid dysfunction.

Pros

+ Basal metabolism increased by 15-25%
+ Testosterone protects from T3 muscle catabolism
+ Very accessible cost (cheap T3)
+ Good tolerance at physiological doses
+ Visible effect on body composition in 3-4 wk

Cons

− Risk of thyroid axis suppression if overdose or long cycle
− Muscle catabolism if AAS dose insufficient
− Palpitations, tremors at high doses
− Excessive sweating, paradoxical fatigue
− Thyroid recovery 2-4 wk post-stop required

10. Test E + Anavar + Cardarine (GW501516) (10 wk) — the endurance cut

Combines androgenic base (moderate Test E) + anti-catabolic (Anavar) + PPARδ agonist (Cardarine). Cardarine is neither a SARM nor an AAS but a PPARδ activator: amplifies lipid oxidation and endurance (Narkar 2008). Uncertain long-term safety profile — preclinical rodent studies have reported carcinogenic risk at high doses (Mitchell 2019; open debate on human extrapolation).

Dose / Duration

Test enanthate 250 mg/wk for 10 wk + Anavar 40 mg/d for 8 wk + Cardarine 10-20 mg/d for 8-10 wk. AI as needed. Hepatoprotectors.

Target audience

Advanced users accepting the cardarine risk profile, endurance + composition athletes, seeking metabolic optimization. Not for risk-averse users or those with family history of cancer.

Pros

+ Recomposition + improved endurance effect
+ Cardarine does not suppress HPG axis
+ Lipolysis (cardarine) + anti-catabolism (anavar) + androgen (test) synergy
+ Increased cardio performance (useful for HIIT training)
+ No additional aromatization

Cons

− Controversial cardarine: carcinogenic risk signaled in rodents (Mitchell 2019)
− Black market: highly variable cardarine product quality
− Unclear legal status (WADA-banned, available as "research chemical")
− No long-term human clinical studies
− Moderate-high cost depending on cardarine source

Final comparison

Protocol	Fat loss 8 wk	Mass preservation	Visual quality	Safety
Test + Anavar	-4 to -6 kg	Excellent	Good	Very good
Test P + Tren A + Winstrol	-6 to -8 kg	Excellent	Maximum	Low
Test + Masteron	-4 to -6 kg	Excellent	Very good	Good
Test + Tren E	-5 to -7 kg	Excellent (gain possible)	Excellent	Medium-low
Test + Primobolan	-4 to -5 kg	Excellent	Very good	Excellent
Test + Anavar + Winstrol	-5 to -7 kg	Good	Excellent	Medium
Test + Halotestin	-3 to -5 kg	Good	Excellent	Low
Test + Clenbuterol	-5 to -7 kg	Good	Good	Medium
Test + T3	-5 to -7 kg	Medium	Good	Medium
Test + Anavar + Cardarine	-5 to -7 kg	Very good	Good	Uncertain (cardarine)

FAQ

What caloric deficit on a cutting cycle?: Moderate deficit (-300 to -500 kcal/d under maintenance) for the majority of cases. The presence of AAS does not justify a more aggressive deficit: on the contrary, the anti-catabolic effect of androgens allows excellent results with a moderate deficit while preserving energy, sleep and training. Helms 2014 and Aragon 2017 (ISSN) recommend 0.5-1% of body weight/wk as optimal loss rate in natural competition; under AAS, aiming for 0.7-1.2% is realistic without degrading performance. Maintenance calculation: Mifflin-St Jeor + activity factor x 1.4-1.7.
How much protein on a cut under AAS?: 2.2 to 2.8 g/kg lean mass/day. Helms 2014 (ISSN) suggests 2.3-3.1 g/kg lean mass for natural bodybuilders in prolonged deficit; under AAS, the anti-catabolic effect of androgens allows targeting the lower range (2.2-2.5 g/kg) without compromising muscle preservation. Spread across 4-5 meals/day of 30-50 g (Schoenfeld 2018: no benefit beyond ~0.4 g/kg/meal in terms of protein synthesis). Sources: lean meat, eggs, fish, whey, late casein snack.
Is cardio needed under a cutting cycle?: Yes, but moderate. 3-4 sessions/wk of moderate cardio (LISS, 30-45 min, 60-70% MHR) or 2-3 short HIIT sessions (15-20 min). Cardio amplifies the caloric deficit and improves lipid profile (HDL up, counterbalancing AAS effect that degrades it). Avoid excessive cardio (>5h/wk) which may compromise muscle recovery and amplify cumulative fatigue. Fasted cardio in the morning: modest effect on lipolysis vs cardio at any time of day (Aragon 2013) — choose timing based on preference and adherence.
Anavar or Winstrol for cutting?: Anavar for prolonged cuts and first cycles (better tolerance, joints preserved). Winstrol for pre-competition 'finishing' (last 4-6 wk, maximum visual hardness). Both are 17α-alkylated and hepatotoxic. Comparative safety: Anavar slightly less hepatotoxic than Winstrol (Niedfeldt 2018), unfavorable lipid profile for both. Joints: Winstrol causes synovial dryness and significant joint pain — Anavar neutral. Women: Anavar almost exclusively (5-10 mg/d) because Winstrol causes virilization in ~30% of women at 10 mg/d.
How much fat can be lost per week on cycle?: 0.7 to 1.2% of body weight/week is realistic and durable under AAS (Helms 2014 — extrapolation for 'enhanced' users). For a 90 kg user, that represents 0.6 to 1.1 kg/wk fat loss with excellent muscle preservation. Beyond 1.5% body weight/wk, muscle loss risk increases significantly even under AAS, and training performance degrades. Over 8 weeks at 1%/wk: -7-8 kg fat for a 90 kg subject, ~9% body fat less (if baseline 18%, end of cycle ~9-10%).
What PCT after a cut?: PCT identical to mass cycles, but timing to adjust according to esters used. Test E + Anavar cycle (long esters): PCT at W+3 post-last injection. Test P + Tren A cycle (short esters): PCT at W+3 days. Standard protocol: Nolvadex 40/40/20/20 mg/d for 4 wk. On a cut, the post-cycle window is particularly sensitive to cortisol rebound and fat regain (rebound effect). Maintain nutrition at maintenance level (not surplus) for 6-8 weeks post-PCT, and reduce cardio gradually. Reference: Rahnema 2014 (ASIH).
Clenbuterol: real safety and dosages?: Clenbuterol is not a harmless product despite its 'mainstream burner' reputation. Spiller 2013 documents cases of acute intoxication (tachycardia, hypokalemia, atrial fibrillation) from 200-300 µg single doses. Cautious dosing: progressive 14-day ramp from 20 → 100 µg/d, ceiling at 120 µg/d, 2 wk on / 2 wk off cycling to limit β2 receptor downregulation (Kamalakkannan 2008). Supplement with taurine (3-5 g/d) and magnesium (400 mg/d) to limit cramps. Contraindicated in subjects with cardiac history, severe anxiety or uncontrolled hypertension.
Recomposition vs pure cut: which strategy?: Recomposition (simultaneous muscle gain + fat loss) is feasible under AAS, but requires precise conditions: intermediate user (not beginner nor elite), moderate baseline body fat (12-18%), AAS with recomposition effect (trenbolone, primobolan). Strategy: very light caloric deficit (-100 to -200 kcal/d) or maintenance, elevated protein (2.5 g/kg lean mass), high training volume. Expected gains: +1-2 kg lean mass and -2-4 kg fat over 10 weeks. Pure cut (deficit -400 kcal/d) remains more predictable and more effective for very low body compositions (<10% fat).